Thoratec Says Lead Failure Update Will Not Slow HeartMate II Momentum
This article was originally published in The Gray Sheet
Executive Summary
New warnings about potential percutaneous lead failures on Thoratec's HeartMate II ventricular assist device will not slow its rapid market adoption, the company predicts